04.22.26 -- A CMC Professional At Sanofi Focuses On Arrangements Over Relationships

See the bigger picture in DEL screening data. This webinar explores how analyzing the full dataset, not just top hits, can uncover meaningful structure-function trends across chemical series. Learn how a broader view can sharpen early synthesis decisions, strengthen series selection, and help discovery teams prioritize smarter while reducing downstream risk in discovery programs. Click here to learn more.

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

Review three of our key compounds — Testosterone Base, Testosterone Cypionate, and Testosterone Propionate — each presented with essential identifiers.

We're a CDMO specializing in oral solid and non-sterile liquid dosage—from early formulation and clinical supplies to commercial manufacturing, packaging, analytics, and regulatory support.

Ian Lafferty and Josh Moule talk through capabilities, project management approach, and provide a virtual tour of their 60,000 sq. ft development and manufacturing facility.

Accelerate the development of small molecules and biologics with integrated CDMO services. Access specialized capabilities from process development to GMP manufacturing and sterile fill/finish.